Atocha Romero Selected Research

Atocha Romero Research Topics

Disease

29	Neoplasms (Cancer) 01/2023 - 12/2015
26	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 10/2016
20	Breast Neoplasms (Breast Cancer) 02/2023 - 04/2011
7	Disease Progression 09/2022 - 09/2017
6	Lung Neoplasms (Lung Cancer) 01/2023 - 08/2017
3	Adenocarcinoma of Lung 12/2023 - 01/2019
3	Circulating Neoplastic Cells 03/2020 - 10/2016
2	Neoplasm Metastasis (Metastasis) 12/2023 - 12/2015
1	Brain Neoplasms (Brain Tumor) 12/2023
1	Polyps 12/2023
1	Adenocarcinoma 12/2023
1	Pruritus (Itching) 01/2023
1	Proteinuria 01/2023
1	Fatigue 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Residual Neoplasm 02/2022
1	Pericardial Effusion 01/2021
1	Pleural Effusion (Pleural Effusions) 01/2021
1	Ascites 01/2021
1	Teratocarcinoma 01/2021
1	Febrile Neutropenia 11/2020
1	Genetic Risk Score 01/2020
1	Fibrosis (Cirrhosis) 01/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Chromosome Fragility 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 04/2015

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 04/2022 - 12/2015
9	Circulating Tumor DNAIBA 10/2022 - 01/2017
9	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2011
6	Estrogen ReceptorsIBA 01/2022 - 12/2017
5	Anaplastic Lymphoma KinaseIBA 12/2023 - 08/2017
5	NivolumabIBA 10/2023 - 11/2020
5	Tyrosine Kinase InhibitorsIBA 12/2022 - 04/2020
4	Cell-Free Nucleic AcidsIBA 09/2022 - 10/2016
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 09/2022 - 01/2021
3	B7-H1 AntigenIBA 01/2023 - 01/2021
3	RNA (Ribonucleic Acid)IBA 01/2023 - 03/2020
2	alectinibIBA 12/2023 - 12/2022
2	Proteins (Proteins, Gene)FDA Link 09/2022 - 01/2019
2	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 01/2017
2	Nucleic AcidsIBA 01/2022 - 12/2016
2	human ERBB2 proteinIBA 01/2022 - 01/2020
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2022 - 01/2020
2	osimertinibIBA 01/2021 - 06/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2019
2	Hormones (Hormone)IBA 01/2021 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 11/2017
2	Formaldehyde (Formol)FDA Link 02/2019 - 12/2015
2	ParaffinIBA 02/2019 - 12/2015
2	AnthracyclinesIBA 03/2012 - 04/2011
1	atezolizumabIBA 01/2023
1	Drug CombinationsIBA 01/2023
1	Bevacizumab (Avastin)FDA Link 01/2023
1	Programmed Cell Death 1 ReceptorIBA 01/2023
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 09/2022
1	Epithelial Cell Adhesion MoleculeIBA 02/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 02/2022
1	Interferon Type IIBA 01/2022
1	ElementsIBA 01/2021
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Lipase (Acid Lipase)FDA Link 11/2020
1	Carboplatin (JM8)FDA LinkGeneric 11/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2020
1	ceritinibIBA 04/2020
1	CrizotinibIBA 04/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	Tamoxifen FDA LinkGeneric 01/2020
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2020
1	Homeodomain Proteins (Proteins, Homeobox)IBA 01/2020
1	olaparibIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	diepoxybutaneIBA 01/2019
1	PlatinumIBA 01/2019
1	A-Form DNA (A-DNA)IBA 01/2019
1	AcidsIBA 12/2016
1	tetraethylpyrazine (TEP)IBA 10/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	3' Untranslated Regions (3' UTR)IBA 01/2016
1	NucleotidesIBA 04/2015
1	EnzymesIBA 03/2012
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 04/2011

Therapy/Procedure

10	Therapeutics 01/2023 - 10/2016
7	Drug Therapy (Chemotherapy) 10/2023 - 03/2012
5	Neoadjuvant Therapy 04/2022 - 11/2020
4	Immunotherapy 04/2022 - 01/2021
3	Radiotherapy 02/2023 - 01/2021
3	Cardiopulmonary Resuscitation (CPR) 01/2022 - 01/2021
1	Gastrectomy 12/2023
1	Aftercare (After-Treatment) 01/2022
1	Drug Tapering 09/2017